...
首页> 外文期刊>Breast cancer research and treatment. >Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer.
【24h】

Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer.

机译:在原发性乳腺癌的同系大鼠模型中,使用实时近红外荧光进行图像引导的肿瘤切除。

获取原文
获取原文并翻译 | 示例
           

摘要

Tumor involvement of resection margins is found in a large proportion of patients who undergo breast-conserving surgery. Near-infrared (NIR) fluorescence imaging is an experimental technique to visualize cancer cells during surgery. To determine the accuracy of real-time NIR fluorescence imaging in obtaining tumor-free resection margins, a protease-activatable NIR fluorescence probe and an intraoperative camera system were used in the EMR86 orthotopic syngeneic breast cancer rat model. Influence of concentration, timing and number of tumor cells were tested in the MCR86 rat breast cancer cell line. These variables were significantly associated with NIR fluorescence probe activation. Dosing and tumor size were also significantly associated with fluorescence intensity in the EMR86 rat model, whereas time of imaging was not. Real-time NIR fluorescence guidance of tumor resection resulted in a complete resection of 17 out of 17 tumors with minimal excision of normal healthy tissue (mean minimum and a mean maximum tumor-free margin of 0.2 +/- 0.2 mm and 1.3 +/- 0.6 mm, respectively). Moreover, the technique enabled identification of remnant tumor tissue in the surgical cavity. Histological analysis revealed that the NIR fluorescence signal was highest at the invasive tumor border and in the stromal compartment of the tumor. In conclusion, NIR fluorescence detection of breast tumor margins was successful in a rat model. This study suggests that clinical introduction of intraoperative NIR fluorescence imaging has the potential to increase the number of complete tumor resections in breast cancer patients undergoing breast-conserving surgery.
机译:在进行保乳手术的患者中,有很大一部分肿瘤累及切除边缘。近红外(NIR)荧光成像是一项在手术过程中可视化癌细胞的实验技术。为了确定实时NIR荧光成像在获得无肿瘤切除切缘中的准确性,在EMR86原位同基因乳腺癌大鼠模型中使用了蛋白酶激活的NIR荧光探针和术中摄像系统。在MCR86大鼠乳腺癌细胞系中测试了肿瘤细胞的浓度,时间和肿瘤细胞数量的影响。这些变量与NIR荧光探针激活显着相关。在EMR86大鼠模型中,剂量和肿瘤大小也与荧光强度显着相关,而成像时间则不相关。实时NIR荧光引导的肿瘤切除术可以完全切除17个肿瘤中的17个,而对正常健康组织的切除最小(平均最小和平均最大无肿瘤切缘为0.2 +/- 0.2 mm和1.3 +/-分别为0.6毫米)。此外,该技术能够识别手术腔内的残留肿瘤组织。组织学分析显示,NIR荧光信号在浸润性肿瘤边界和肿瘤基质腔室中最高。总之,在大鼠模型中,NIR荧光检测乳腺肿瘤切缘是成功的。这项研究表明,术中近红外荧光成像的临床引入可能会增加接受保乳手术的乳腺癌患者中完整肿瘤切除术的数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号